Standard Contracts
AMENDMENT TO SECOND AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENTInformation and Registration Rights Agreement • April 3rd, 2006 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus
RECITALSInformation and Registration Rights Agreement • April 23rd, 2002 • Bentley Systems Inc • Delaware
NEXTEST SYSTEMS CORPORATION INFORMATION AND REGISTRATION RIGHTS AGREEMENTInformation and Registration Rights Agreement • December 2nd, 2005 • Nextest Systems Corp • Instruments for meas & testing of electricity & elec signals • California
THIS INFORMATION AND REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of November 27, 2001, by and among Nextest Systems Corporation, a California corporation (the “Company”), and the persons listed on the attached Exhibit A who become signatories to this Agreement (collectively, the “Investors”).
EX-10.1 6 a2225104zex-10_1.htm EX-10.1 CONFORMIS, INC. AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT June 15, 2015 CONFORMIS, INC. AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENTInformation and Registration Rights Agreement • May 5th, 2020 • New York
THIS AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of June 15, 2015 by and among ConforMIS, Inc., a Delaware corporation (the “Company”), and the persons listed on the attached Exhibit A (each an “Investor” and, collectively, the “Investors”).
EX-4.1 6 dex41.htm AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT CORUS PHARMA, INC. AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT April 9, 2004 Initial Closing: April 9, 2004 Second Closing: April 21, 2004...Information and Registration Rights Agreement • May 5th, 2020 • Delaware
THIS AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of April 9, 2004, by and among Corus Pharma, Inc., a Delaware corporation (the “Company”), and the undersigned holders of shares of the Company’s Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock listed on the attached Exhibit A, as it may be amended from time to time pursuant to the terms hereof (collectively, the “Investors”).
Amendment to Amended and Restated Information and Registration Rights AgreementInformation and Registration Rights Agreement • May 1st, 2014 • Synageva Biopharma Corp • Biological products, (no disgnostic substances) • California
This Amendment to the Amended and Restated Information and Registration Rights Agreement (this “Amendment”) is made and entered into as of May 1, 2014 by and among Synageva BioPharma Corp., a Delaware corporation (the “Company”) and the persons who are signatories to this Amendment (collectively, the “Investors”). Capitalized terms used herein without definition shall have the meanings ascribed to them in the Amended and Restated Information and Registration Rights Agreement, dated as of April 1, 2009, between the Company and the Investors, as amended (the “Agreement”).
RECITALSInformation and Registration Rights Agreement • June 16th, 1998 • Terayon Communication Systems • California
CONFORMIS, INC. AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT June 29, 2015Information and Registration Rights Agreement • June 29th, 2015 • ConforMIS Inc • Orthopedic, prosthetic & surgical appliances & supplies • New York
THIS AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is entered into as of June 29, 2015 by and among ConforMIS, Inc., a Delaware corporation (the “Company”), and the persons listed on the attached Exhibit A (each an “Investor” and, collectively, the “Investors”).
CORCEPT THERAPEUTICS INCORPORATED AMENDMENT NO. 1 TO AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENTInformation and Registration Rights Agreement • March 19th, 2004 • Corcept Therapeutics Inc • Pharmaceutical preparations
THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT (the “Amendment”) is made as of March 16, 2004 by and among Corcept Therapeutics Incorporated, a Delaware corporation (the “Company”), and the persons and entities listed on the attached Exhibit A (collectively, the “Investors”).
SYNAGEVA BIOPHARMA CORP. AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT April 1, 2009 Amended September 25, 2009 Amended March 15, 2011 Amended November 2, 2011Information and Registration Rights Agreement • January 4th, 2012 • Synageva Biopharma Corp • Biological products, (no disgnostic substances) • California
THIS AMENDED AND RESTATED INFORMATION AND REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of April 1, 2009 by and among SYNAGEVA BIOPHARMA CORP., a Delaware corporation (the “Company”), and the persons listed on the attached Schedule 1.1 who are signatories to this Agreement (collectively, the “Investors”).
